Adenocarcinoma of Lung
Oncology
2
Pipeline Programs
3
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
1
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
GenomicsUK - Oxford
1 programComparative Genomic Profiling of Lung Adenocarcinoma in Asians and Caucasians: A Propensity Matched N/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
CelltrionCT-P16
Lantern PharmaLP-300
GenomicsComparative Genomic Profiling of Lung Adenocarcinoma in Asians and Caucasians: A Propensity Matched
Clinical Trials (3)
Total enrollment: 1,229 patients across 3 trials
To Compare Efficacy and Safety of CT-P16 and European Union-Approved Avastin as First-Line Treatment for Metastatic or Recurrent Non-Squamous Non-Small Cell Lung Cancer
Start: Feb 2019Est. completion: Sep 2023689 patients
Phase 3Completed
A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma
Start: Mar 2023Est. completion: Jun 202690 patients
Phase 2Recruiting
NCT04692935GenomicsComparative Genomic Profiling of Lung Adenocarcinoma in Asians and Caucasians: A Propensity Matched
Comparative Genomic Profiling of Lung Adenocarcinoma in Asians and Caucasians: A Propensity Matched Analysis
Start: Jan 2021Est. completion: Dec 2021450 patients
N/AUnknown
Related Jobs in Oncology
Cell Therapy Account Manager（北陸）
Gilead Sciences
Japan - Tokyo
Just now
Leo Cancer Care: Senior In-House Counsel/General Counsel
Leo Cancer Care
Middleton, Wisconsin
6h ago
Summer Intern - Computational Chemistry & Artificial Intelligence
Arvinas
Remote
8h ago
Executive Medical Director, Oncology Early Development
AbbVie
Florham Park, NJ
8h ago
Executive Medical Director, Oncology Early Development
AbbVie
South San Francisco, CA
8h ago
Executive Medical Director, Oncology Early Development
AbbVie
North Chicago, IL
8h ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 late-stage (Phase 3) programs — potential near-term approvals
1 actively recruiting trials targeting 1,229 patients
3 companies competing in this space